News | April 26, 2012

SCAI Attendees Discuss Strategies to Reduce Costs, Eliminate Waste, Ensure Appropriate Use

April 26, 2012 — Interventional cardiologists can and should lead efforts to improve quality, cut costs and ensure appropriate use of procedures. Elliott Fisher, M.D., MPH, professor of medicine at Dartmouth, an internationally recognized expert on variations in health system performance and one of the originators of the concept of accountable care organizations, will challenge the interventional cardiology community to accomplish these and other goals at a town hall meeting during the 2012 Scientific Sessions of the Society for Cardiovascular Angiography and Interventions (SCAI) in Las Vegas. His keynote address, “Why Interventional Cardiology Needs to be a Change Leader,” will set the stage for an interactive discussion with cardiologists attending the conference.

In his keynote address, Fisher will speak about the need for payment reform, the future of healthcare, why these changes are critical now and how interventional cardiologists can help lead the successful transformation of the U.S. healthcare system.

“Our health system simply cannot afford to continue the same patterns and models of care delivery that we have relied on in decades past,” said Fisher. “As physicians, we need to be leading the effort to put the systems in place that will result in both improved patient care and reduced costs. As a specialty, interventional cardiology has led the way in evidence-based care and quality improvement. I intend to deliver a message of challenge, hope and choice — and by that I mean, face up to our current fiscal predicament, realize this is a moment of opportunity and make the choice to fix it. If interventional cardiologists do this, they will be demonstrating to the larger healthcare community how these things can be done.”

An open discussion about the state of interventional cardiology will follow the keynote, featuring a panel of leading interventional cardiologists. Town hall faculty will share specific examples of how interventional cardiologists can continue their efforts to improve safety and quality through quality improvement initiatives, such as:

- Lessons from recent cases of alleged inappropriate and overuse of stenting in Maryland, presented by Mark Turco, M.D., FSCAI
- Cath lab accreditation to promote quality improvement in interventional cardiology, presented by Accreditation for Cardiovascular Excellence (ACE) Chief Medical Officer Bonnie Weiner, M.D., FSCAI
- SCAI’s Quality Improvement Toolkit (QIT), featuring guidelines and tools focused on peer-review conferences, random case selection, national database participation, pre-procedure checklists and other tools to aid in continuous quality improvement, presented by Jeffrey Marshall, M.D., FSCAI
- SCAI’s appropriate use criteria (AUC) smartphone application, providing interventional cardiologists easy access to relevant guidelines and the ability to instantaneously calculate “appropriateness,” presented by Kalon Ho, M.D., FSCAI

“Already the interventional cardiology community is leading important initiatives aimed at improving the quality of care. The vast majority of us are deeply committed to doing the right thing for our patients,” said SCAI 2012 program co-director Kenneth Rosenfield,
M.D., FSCAI. “Now we need all interventional cardiologists to join together in this mission. We have the opportunity to make a significant impact on cost and value in our profession and in the larger healthcare system.”

An interactive discussion with attendees will follow the presentations. The Town Hall session will take place Friday, May 11, 2012 from 11 a.m. to 12:45 p.m. (Pacific time).

For more information: www.scai.org

Related Content

Patients undergoing cardiac catheterization are traditionally instructed to follow nothing by mouth, or nil per os (NPO), as there are no current standardized fasting protocols, but the CHOWNOW study found patients do not need to fast and will have similar outcomes. #SCAI2020
Feature | Cath Lab | May 18, 2020
May 18, 2020 – Patients undergoing cardiac catheterization are traditionally instructed to follow nothing by mouth, o
htisham Mahmud, M.D., FSCAI, president of the Society for Cardiovascular Angiography and Interventions (SCAI) and chief, Division of Cardiovascular Medicine at UC San Diego Medical Center,
Podcast | Cath Lab | May 13, 2020
This podcast is an interview with Ehtisham Mahmud, M.D., FSCAI, president of the Society for Cardiovascular Angiograp
Nuance Communications Inc. introduced Nuance Cardiovascular CAPD, a new computer-assisted physician documentation (CAPD) solution designed to help cardiologists improve the quality of complex documentation and the accuracy of reimbursement for cardiac catheterization procedures. The Nuance Cardiovascular CAPD solution is available through a partnership with ZHealth for this solution, which is based on patented algorithms built with ZHealth’s interventional documentation and coding expertise.
News | Cath Lab | January 31, 2020
January 29, 2020 – Nuance Communications Inc.
Videos | Cath Lab | January 09, 2020
Haval Chweich, M.D., medical director of the cardiac critical care unit (CCU) at Tufts Medical Center, and assistant...
People watch the live presentation of the five-year EXCEL Trial data by Gregg Stone, M.D., in the Abbott booth at TCT 2019. Abbott makes the Xience stent used in the trial, which compared equally with long-term CABG surgical outcomes.  In early December 2019, leaders of the European Association for Cardiothoracic Surgery (EACTS) withdrew their support for European practice guidelines that endorse the use of coronary stents in many patients with left main coronary artery disease.

People watch the live presentation of the five-year EXCEL Trial data by Gregg Stone, M.D., in the Abbott booth at TCT 2019. Abbott makes the Xience stent used in the trial, which compared equally with long-term CABG surgical outcomes.

News | Cath Lab | January 02, 2020 | Dave Fornell, Editor
January 2, 2020 — In early December 2019, leaders of the European As...
News | Cath Lab | December 18, 2019
December 18, 2019 — Cook Medical initiated a recall of its CrossCath Support Catheters in November, which the U.S.